Microglia, brain-resident innate immune cells, have been extensively studied in
neurodegenerative contexts like Alzheimer's disease. The Coronavirus disease 2019 …

Many newly emerging and re-emerging viruses have neuroinvasive potential, underscoring
viral encephalitis as a global research priority. Upon entry of the virus into the CNS, severe …

Abstract Coronavirus disease 2019 (COVID-19) is primarily a respiratory disease causing a
worldwide pandemic in the year of 2019. SARS‐CoV‐2 is an enveloped, positive-stranded …

Although COVID-19 is mostly a pulmonary disease, it is now well accepted that it can cause
a much broader spectrum of signs and symptoms and affect many other organs and tissue …

The emergence of new SARS-CoV-2 variants continues to pose an enormous public health
concern. The SARS-CoV-2 infection disrupted host immune response accounting for …

ABSTRACT During the 2015–2016 Zika virus (ZIKV) epidemic, ZIKV-associated
neurological diseases were reported in adults, including microcephaly, Guillain-Barre …

The SARS-CoV-2 virus that led to COVID-19 is associated with significant and long-lasting
neurologic symptoms in many patients, with an increased mortality risk for people with …

As the Coronavirus Disease 2019 (COVID-19) pandemic continues, there is a growing
concern regarding the relationship between viral infections and neuropathic pain. Chronic …

Viruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), use
respiratory epithelial cells as an entry point for infection. Within the nasal cavity, the olfactory …

SARS-CoV-2 spike proteins have been shown to cross the blood–brain barrier (BBB) in
mice and affect the integrity of human BBB cell models. However, the effects of SARS-CoV-2 …